As of May 27
| +0.65 / +1.64%|
The 14 analysts offering 12-month price forecasts for Seattle Genetics Inc have a median target of 43.00, with a high estimate of 65.00 and a low estimate of 30.00. The median estimate represents a +6.86% increase from the last price of 40.24.
The current consensus among 17 polled investment analysts is to Buy stock in Seattle Genetics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.